Health2Sync Chronic Disease Management Platform

Health2Sync is a Taiwan-based digital therapeutics and chronic disease management company founded in 2013 and led by CEO Ed Deng. It addresses the shortage of care for people with diabetes in Asia, where more than half of the world's patients live and most do not receive adequate follow-up.

Patients log blood glucose, blood pressure, weight, meals and medication in the Health2Sync app, with device syncing, CGM data, AI food recognition and lab report scanning. Clinicians use the browser-based Patient Management Platform to prioritise patients, review data from the app and third-party sources, and message patients. The company works with pharma, device makers, insurers, governments and hospitals, and in 2023 obtained Taiwan approval for Insultrate, a basal insulin titration software as a medical device.

• Patient app: logging of glucose, blood pressure, weight, meals and medication with reminders and tips.
• Device and CGM syncing: connects meters, CGMs, Google Health Connect and connected insulin caps.
• AI food recognition: estimates meal content and volume from photos.
• Patient Management Platform: browser-based dashboard to prioritise and message patients.
• Insultrate: basal insulin titration software approved as a medical device in Taiwan.
• Partner programmes: co-developed services such as DigiCoach, a CGM-based prevention programme.

Endocrinology departments in Vietnamese hospitals can use the platform to follow up diabetes patients between visits. Pharma companies can run patient support programmes for insulin users with connected pens. Health insurers and large employers can offer CGM-based prevention programmes to members at risk of diabetes.

Users with an initial HbA1c above 7% saw an average 2.0% drop after 3 months, according to the company. Lets clinics manage thousands of patients remotely; one clinic reports managing over 5,000 patients on the platform. No installation is needed for care teams, and a free trial is offered. ISO 27001 and ISO 27017 certified cloud services support hospital data security reviews.

Asia carries the largest diabetes burden in the world, and payers are starting to reimburse digital follow-up, as Taiwan's National Health Insurance digital care project shows. Pharma companies use digital companions to support insulin and GLP-1 adherence. Vietnam's rising diabetes prevalence and overloaded endocrinology clinics create similar demand for remote monitoring.

Founded in 2013; operates in Taiwan, Japan, Singapore, Australia and South Korea with 1.6 million users. Listed on Taiwan's TPEx Emerging Stock Market in November 2025; raised US$20 million in March 2025. Named Forbes Asia 100 To Watch 2025. Partners include Sanofi, Novo Nordisk, Abbott, Singapore's Health Promotion Board and Japanese Kenpo insurers.